Zachary Hemenway

Zachary Hemenway serves as a key procurement professional within the CDC Office of Acquisition Services, supporting the agency’s mission to safeguard public health through strategic acquisition of critical biomedical and diagnostic capabilities. He manages a portfolio of complex contracts focused on laboratory diagnostics, infectious disease detection systems, and data-driven public health infrastructure, ensuring timely delivery of mission-critical goods and services to support national disease surveillance and rapid response operations. His work directly enables CDC’s scientific and operational readiness by facilitating access to advanced technologies and specialized medical supply chains. Hemenway maintains enduring partnerships with leading providers in the public health and life sciences sectors, including General Dynamics Information Technology, Inc., Cepheid, GlaxoSmithKline, LLC, New York City Health & Hospitals Corp, and MRIGLOBAL. These relationships are characterized by long-term collaboration on high-priority, technically complex procurements involving molecular diagnostics, biosafety equipment, epidemiological data platforms, and clinical research support services. His contracting approach emphasizes performance-based requirements, risk mitigation, and compliance with federal health security standards. A defining feature of Hemenway’s procurement strategy is his exclusive reliance on Total Small Business Set-Aside authorities under FAR 19.5, demonstrating a steadfast commitment to expanding economic opportunity for small businesses within the public health supply chain. All his acquisitions are structured to maximize participation by small disadvantaged, woman-owned, and other socioeconomically disadvantaged firms, aligning with federal mandates to promote equitable access to federal contracting opportunities. His technical focus is centered on NAICS 325120 (Industrial Gas Manufacturing), reflecting his specialization in procuring specialized medical gases, cryogenic storage systems, and associated infrastructure essential for vaccine distribution, specimen preservation, and laboratory operations. This deep domain expertise ensures the agency maintains resilient, compliant, and scalable supply chains for high-stakes public health interventions.